MycoMedica
PrivateLast Round
Series A
Jun 1, 2022
Total Funding Raised
$60M
Momentum Score
25 /100
Company Overview
MycoMedica Life Sciences is a biotechnology company focused on developing genome drugs that harness the healing potential of fungi to benefit both people and the planet.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Biotechnology, Supply Chain, Fashion & Beauty, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MycoMedica Comps
Public and private peers based on sector, stage, and business model.
MycoMedica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2022 |
Key People
Founding team and executive leadership
MycoMedica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Obvious Ventures | Series A |
| KittyHawk Ventures | Series A |
| True Ventures | Series A |
MycoMedica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MycoMedica's valuation, stock price, and market status.